Concord Biotech consolidated net profit rises 9.36% in the June 2024 quarter

Net profit of Concord Biotech rose 9.36% to Rs 59.59 crore in the quarter ended June 2024 as against Rs 54.49 crore during the previous quarter ended June 2023. Sales rose 10.76% to Rs 215.80 crore in the quarter ended June 2024 as against Rs 194.83 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	215.80	194.83	11
OPM %	37.66	37.03	-
PBDT	92.70	84.08	10
PBT	79.52	71.04	12
NP	59.59	54.49	9